149 related articles for article (PubMed ID: 31022503)
21. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip.
Grayson AC; Voskerician G; Lynn A; Anderson JM; Cima MJ; Langer R
J Biomater Sci Polym Ed; 2004; 15(10):1281-304. PubMed ID: 15559850
[TBL] [Abstract][Full Text] [Related]
22. Site-specific drug delivery to pilosebaceous structures using polymeric microspheres.
Rolland A; Wagner N; Chatelus A; Shroot B; Schaefer H
Pharm Res; 1993 Dec; 10(12):1738-44. PubMed ID: 8302759
[TBL] [Abstract][Full Text] [Related]
23. A study of systemic and topical effects of topical steroid application through the comparison of two application schedules.
Fukaya Y; Masutani M; Koyama Y; Takahashi H; Ueda H
J Dermatol; 1990 Jan; 17(1):28-33. PubMed ID: 2329214
[TBL] [Abstract][Full Text] [Related]
24. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.
Carrasquillo KG; Ricker JA; Rigas IK; Miller JW; Gragoudas ES; Adamis AP
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):290-9. PubMed ID: 12506087
[TBL] [Abstract][Full Text] [Related]
25. Engineering microenvironment of biodegradable polyester systems for drug stability and release control.
Khaliq NU; Chobisa D; Richard CA; Swinney MR; Yeo Y
Ther Deliv; 2021 Jan; 12(1):37-54. PubMed ID: 33397135
[TBL] [Abstract][Full Text] [Related]
26. Topical corticosteroid delivery into human skin using hydrofluoroalkane metered dose aerosol sprays.
Reid ML; Benaouda F; Khengar R; Jones SA; Brown MB
Int J Pharm; 2013 Aug; 452(1-2):157-65. PubMed ID: 23684656
[TBL] [Abstract][Full Text] [Related]
27. PLGA microparticles: possible vehicles for topical drug delivery.
de Jalón EG; Blanco-Príeto MJ; Ygartua P; Santoyo S
Int J Pharm; 2001 Sep; 226(1-2):181-4. PubMed ID: 11532580
[TBL] [Abstract][Full Text] [Related]
28. Biodegradable microspheres for vitreoretinal drug delivery.
Herrero-Vanrell R; Refojo MF
Adv Drug Deliv Rev; 2001 Oct; 52(1):5-16. PubMed ID: 11672871
[TBL] [Abstract][Full Text] [Related]
29. Local delivery of mometasone furoate from an eluting endotracheal tube.
Abu Ammar A; Gruber M; Martin P; Stern O; Jahshan F; Ertracht O; Sela E; Srouji S; Zussman E
J Control Release; 2018 Feb; 272():54-61. PubMed ID: 29331580
[TBL] [Abstract][Full Text] [Related]
30. Drug-coated microneedles for rapid and painless local anesthesia.
Baek SH; Shin JH; Kim YC
Biomed Microdevices; 2017 Mar; 19(1):2. PubMed ID: 28070698
[TBL] [Abstract][Full Text] [Related]
31. Bicellar systems as new delivery strategy for topical application of flufenamic acid.
Rubio L; Alonso C; Rodríguez G; Cócera M; López-Iglesias C; Coderch L; De la Maza A; Parra JL; López O
Int J Pharm; 2013 Feb; 444(1-2):60-9. PubMed ID: 23357252
[TBL] [Abstract][Full Text] [Related]
32. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
33. Polymer conjugated retinoids for controlled transdermal delivery.
Castleberry SA; Quadir MA; Sharkh MA; Shopsowitz KE; Hammond PT
J Control Release; 2017 Sep; 262():1-9. PubMed ID: 28690160
[TBL] [Abstract][Full Text] [Related]
34. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
35. Nanostructured ultra-thin patches for ultrasound-modulated delivery of anti-restenotic drug.
Vannozzi L; Ricotti L; Filippeschi C; Sartini S; Coviello V; Piazza V; Pingue P; La Motta C; Dario P; Menciassi A
Int J Nanomedicine; 2016; 11():69-91. PubMed ID: 26730191
[TBL] [Abstract][Full Text] [Related]
36. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
[TBL] [Abstract][Full Text] [Related]
37. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
[TBL] [Abstract][Full Text] [Related]
38. Tunable sustained release drug delivery system based on mononuclear aqueous core-polymer shell microcapsules.
Abulateefeh SR; Alkawareek MY; Alkilany AM
Int J Pharm; 2019 Mar; 558():291-298. PubMed ID: 30641178
[TBL] [Abstract][Full Text] [Related]
39. Delivery of Methotrexate and Characterization of Skin Treated by Fabricated PLGA Microneedles and Fractional Ablative Laser.
Nguyen HX; Banga AK
Pharm Res; 2018 Feb; 35(3):68. PubMed ID: 29468316
[TBL] [Abstract][Full Text] [Related]
40. Amphotericin B-Loaded Poly(lactic-co-glycolic acid) Nanofibers: An Alternative Therapy Scheme for Local Treatment of Vulvovaginal Candidiasis.
Souza RO; Henrique de Lima T; Oréfice RL; de Freitas Araújo MG; de Lima Moura SA; Magalhães JT; da Silva GR
J Pharm Sci; 2018 Oct; 107(10):2674-2685. PubMed ID: 29940181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
